Clinical Trial Update: A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Bendavia (MTP-131) for skeletal muscle mitochondrial dysfunction in the elderly has completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skeletal Muscle Mitochondrial Dysfunction in the Elderly

Drugs mentioned

• Bendavia (MTP-131)

Snippet

Sponsor: Stealth BioTherapeutics Inc. | Conditions: Skeletal Muscle Mitochondrial Dysfunction in the Elderly | Phase 2 | Status: COMPLETED | Results posted: 2020-06-23